Conference
CANCER CHEMOTHERAPY AND THROMBOSIS
Abstract
Malignant disease is recognized as a risk factor for venous thromboembolism. A number of recent reports have suggested that cancer chemotherapy may contribute to this risk, but it was not possible to separate the role of chemotherapy from the effects of the malignant disease. We are conducting a randomized trial to determine the optimal duration of adjuvant chemotherapy in women with Stage II breast carcinoma. These ambulatory patients, with …
Authors
Levine M; Arnold A; Kelleher L; Lord S; Hryniuk W; Hrish J; Gent M
Volume
58
Pagination
pp. 114-114
Publisher
Thieme
Publication Date
1987
DOI
10.1055/s-0038-1643203
Name of conference
XIth International Congress on Thrombosis and Haemostasis
Conference proceedings
Thrombosis and Haemostasis
Issue
01
ISSN
0340-6245